MedTrace Logo

Research on the Treatment of Severe Community-acquired Pneumonia in Children

NCT05768204 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-03-14

No results posted yet for this study

Summary

The need for glucocorticoid therapy in children with severe community-acquired pneumonia in the acute phase of the disease remains unclear. The implementation of this study could provide strong evidence on the need for adjuvant glucose therapy in children with severe community-acquired pneumonia.

Conditions

  • Severe Pneumonia

Interventions

DRUG

Prednisolone Acetate

The experimental group took prednisolone acetate which is a kind of oral glucocorticoid.

OTHER

placebo

A placebo consistent in appearance with the prednisolone acetate.

Sponsors & Collaborators

  • Baoping XU

    lead OTHER

Principal Investigators

  • Baoping Xu · Beijing Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-10
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05768204 on ClinicalTrials.gov